-
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialWang TY, Kaltenbach LA, Cannon CP et al. -
Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and ProgressLJ He, NB Nguyen, R Ardehali et al.
-
Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary SyndromeBarger LK, Rajaratnam SMW, Cannon CP et al.
-
Deficiency of GATA3-Positive Macrophages Improves Cardiac Function Following Myocardial Infarction or Pressure Overload HypertrophyMJ Yang, L Song, L Wang et al.
-
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary InterventionP Tricoci, LK Newby et al.
-
Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary SyndromeS Stojkovic, PP Wadowski, P Haider et al.
-
Impact of Chronic Total Coronary Occlusion Location on Long-term Survival After Percutaneous Coronary InterventionAhn JH, Yang JH, Choi SH et al.
-
Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH TrialGJ Vlachojannis , JM Wilschut , RF Vogel et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
